<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03574116</url>
  </required_header>
  <id_info>
    <org_study_id>6808</org_study_id>
    <nct_id>NCT03574116</nct_id>
  </id_info>
  <brief_title>Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?</brief_title>
  <official_title>Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study of sarcopenia is a subject that is the subject of numerous research and
      publications, particularly because of its link with a poor prognosis for many cancers.

      In an article published by the digestive surgery team, the role of feeding jejunostomy has
      been demonstrated: it allowed more patients to reach the 2nd stage of surgery and a better
      tolerance of chemotherapy.

      Investigators wanted to study retrospectively the impact of feeding jejunostomy on
      radiological sarcopenia. Is the positive effect of jejunostomy in gastric cancers associated
      with a decrease in sarcopenia?
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 31, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate muscle status by CT evaluation of sarcopenia in patients</measure>
    <time_frame>24 hour after the realization of the MRI</time_frame>
    <description>Evaluate the impact of feeding jejunostomy in patients with gastric cancer</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sarcopenia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subject with Stage IB Gastric Cancer and having benefited from the placement or not of a
        feeding jejunostomy and a control CT performed at the HUS, after the end of the courses of
        chemotherapy and / or before the surger
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Criteria for inclusion:

          -  Age 18-80 years

          -  Sex: H or F

          -  Subject giving their consent for their participation

          -  Gastric cancers

          -  stage&gt; IB

          -  whether or not a feeding jejunostomy

          -  CT scan performed at the HUS, after the end of the courses of chemotherapy and / or
             before the surgery.

        Exclusion criteria:

          -  antecedent level L3 surgery,

          -  psoas hematoma

          -  No CT performed at HUS at the end of chemotherapy and / or before surgery

          -  Impossibility of giving the subject informed information

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francis VEILLON, MD, PhD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>Francis.veillon@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aïna VENKATASAMY, MD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>aina.venkatasamy@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Imagerie 1</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>Francis.veillon@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aïna VENKATASAMY, MD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>aina.venkatasamy@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aïna VENKATASAMY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 31, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2018</study_first_posted>
  <last_update_submitted>July 4, 2018</last_update_submitted>
  <last_update_submitted_qc>July 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>jejunostomy</keyword>
  <keyword>oesogastric adenocarcinoma</keyword>
  <keyword>scanography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

